Stay updated on Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T22:39:21.000Z thumbnail image
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the drug levels of ipilimumab given under the skin alone and in combination with nivolumab in multiple tumor types in a Phase 1/2 pharmacokinetic multi-tumor study.
    Difference
    0.2%
    Check dated 2024-06-06T14:49:22.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed information about eligibility criteria for clinical trial participants, including examples such as general health condition and prior treatments. Additionally, it now includes a link for more information on Bristol-Myers Squibb Clinical Trial participation and specific inclusion and exclusion criteria for the study.
    Difference
    21%
    Check dated 2024-05-22T21:37:15.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:28:55.000Z thumbnail image

Stay in the know with updates to Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Ipi Alone and With Nivo in Tumors Clinical Trial page.